Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19.
Lung
; 201(2): 159-170, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-37000214
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Lung
Year:
2023
Document type:
Article
Affiliation country:
Italy
Country of publication:
United States